Cardlytics Inc diskutieren

Cardlytics, Inc. (NASDAQ: CDLX) had its price target lowered by analysts at Needham & Company LLC from $14.00 to $8.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target lowered by analysts at Wells Fargo & Company from $6.00 to $5.00. They now have an "underweight" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target raised by analysts at Wells Fargo & Company from $5.00 to $6.00. They now have an "underweight" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target raised by analysts at Needham & Company LLC from $10.00 to $19.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target lowered by analysts at Needham & Company LLC from $19.00 to $12.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $13.00 price target on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock, up previously from $10.00.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target raised by analysts at Lake Street Capital from $13.00 to $18.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target lowered by analysts at Needham & Company LLC from $17.00 to $12.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its price target lowered by analysts at Craig Hallum from $18.00 to $12.00. They now have a "buy" rating on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $14.00 price target on the stock.

Cardlytics, Inc. (NASDAQ: CDLX) was upgraded by analysts at Northland Capmk to a "strong-buy" rating.

Based on the latest news and financial data, I'm a bit hesitant about Cardlytics Inc. at the moment. The recent insider selling by top executives, like the Chief Legal & Privacy Officer, Chief Operating Officer, and Chief Financial Officer, is a red flag for me. It makes me wonder if they're losing confidence in the company's prospects. Additionally, the valuation metrics suggest the stock may be overpriced compared to its fundamentals. While the company has some interesting offerings in the loyalty and marketing analytics space, the competitive landscape is getting tougher. I'd be inclined to sell this stock and wait for a better entry point, as I see limited upside potential in the near term. The downside risk seems to outweigh the potential rewards at this valuation.